Respiri Limited announced that following an extensive executive search, Mr. William Sigsbee has been appointed as the Chief Commercial Officer for the US market reporting directly to Respiri CEO and Managing Director, Marjan Mikel. With more than 30 years of healthcare experience in medical devices, services and software solutions, including previous roles as Chief Executive Officer (CEO), Mr. Sigsbee brings a wealth of knowledge around the US healthcare market, partnership strategy and distribution of patient engagement technologies. Mr. Sigsbee will be supported by Respiri CEO, Marjan Mikel who will continue to provide overall Company leadership and on-the-ground support in the USA.

Mr. Sigsbee led Medicom Health Interactive, as CEO, serving more than 120 of the largest healthcare systems in the US. He was instrumental in developing and executing product, pricing, marketing sales and channel strategies for health assessment tools that are in use in more than 1000 hospitals. He led the company from pre-revenue custom software developer, to a healthcare platform SaaS company, growing at 30% CAGR, with 89% GM & 15% EBITDA in 2020.

Most recently, following the sale, Mr. Sigsbee worked as a consultant with a number of companies in the Remote Patient Monitoring/Telehealth space, building go-to-market and patient-engagement strategy.